DK672789D0 - Nukleinsyresekvens samt rekombinant vaertscelle transformeret med samme - Google Patents

Nukleinsyresekvens samt rekombinant vaertscelle transformeret med samme

Info

Publication number
DK672789D0
DK672789D0 DK672789A DK672789A DK672789D0 DK 672789 D0 DK672789 D0 DK 672789D0 DK 672789 A DK672789 A DK 672789A DK 672789 A DK672789 A DK 672789A DK 672789 D0 DK672789 D0 DK 672789D0
Authority
DK
Denmark
Prior art keywords
nucleic acid
fipv
recombinant
acid sequence
same
Prior art date
Application number
DK672789A
Other languages
English (en)
Other versions
DK672789A (da
DK174187B1 (da
Inventor
Beverly Dale
Miles Yamanaka
William N Acree
Jr Lloyd G Chavez
Original Assignee
California Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Biotechnology Inc filed Critical California Biotechnology Inc
Publication of DK672789D0 publication Critical patent/DK672789D0/da
Publication of DK672789A publication Critical patent/DK672789A/da
Application granted granted Critical
Publication of DK174187B1 publication Critical patent/DK174187B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1002—Coronaviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DK198906727A 1988-12-30 1989-12-29 Rekombinant ekspressionssystem omfattende en nukleinsyresekvens, der koder for E1- eller N-proteinet af felin infektiøs peritonitis virus (FIPV), rekombinant ekspressionsvektor omfattende ekspressionssystemet, rekombinante værtsceller DK174187B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29252788A 1988-12-30 1988-12-30
US29252788 1988-12-30

Publications (3)

Publication Number Publication Date
DK672789D0 true DK672789D0 (da) 1989-12-29
DK672789A DK672789A (da) 1990-07-01
DK174187B1 DK174187B1 (da) 2002-08-26

Family

ID=23125039

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198906727A DK174187B1 (da) 1988-12-30 1989-12-29 Rekombinant ekspressionssystem omfattende en nukleinsyresekvens, der koder for E1- eller N-proteinet af felin infektiøs peritonitis virus (FIPV), rekombinant ekspressionsvektor omfattende ekspressionssystemet, rekombinante værtsceller

Country Status (12)

Country Link
US (2) US5780266A (da)
EP (1) EP0376744B1 (da)
JP (1) JP2903129B2 (da)
AT (1) ATE126537T1 (da)
AU (1) AU640356B2 (da)
CA (1) CA2005291C (da)
DE (1) DE68923862T2 (da)
DK (1) DK174187B1 (da)
ES (1) ES2078246T3 (da)
GR (1) GR3017770T3 (da)
IE (1) IE67650B1 (da)
NZ (1) NZ231850A (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
CA2020740A1 (en) * 1989-07-12 1991-01-13 Harry Vennema Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
PT510773E (pt) * 1991-04-25 2004-04-30 Akzo Nobel Nv Vacina subunidade do coronavirus canino
EP0524672A1 (en) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV vaccine
WO1993015762A1 (en) * 1992-02-18 1993-08-19 Parhelion Corporation Feline infectious peritonitis vaccine and method of preparation
ATE225805T1 (de) * 1992-05-08 2002-10-15 Pfizer Hundecoronavirus s gen und verwendung davon
EP0640097A4 (en) * 1992-05-08 1997-01-15 Smithkline Beecham Corp COMPOSITION AND METHODS FOR VACCINATING AGAINST CORONAVIRES (01/20/94).
GB2316681B (en) * 1993-09-16 1998-04-15 Dimminaco Ag Sa Ltd Antigenically active proteins/polypeptides and coronavirus vaccines containing the same
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
US5858373A (en) * 1995-12-01 1999-01-12 Virogenetics Corporation Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them
WO1998027433A1 (en) * 1996-12-18 1998-06-25 Engene Biotechnologies, Inc A specific diagnostic for antibodies to feline infectious peritonitis virus
US7255986B2 (en) * 2002-01-31 2007-08-14 The Board Of Trustees Operating Michigan State University Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
JP4242607B2 (ja) * 2002-07-04 2009-03-25 学校法人北里研究所 ネコ伝染性腹膜炎ワクチン
EP1668112A4 (en) 2003-06-20 2009-04-29 Protein Sciences Corp SARS IMMUNOGENOUS EXPRESSING VECTORS, SUCH VECTORS OR EXPRESSION PRODUCTS COMPRISING THOSE COMPOSITIONS, PROCESSES AND TESTS FOR THE PREPARATION AND USE THEREOF
RU2480756C2 (ru) * 2011-02-10 2013-04-27 Государственное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ прогнозирования течения послеоперационного периода у больных с перитонитом
WO2015077717A1 (en) 2013-11-25 2015-05-28 The Broad Institute Inc. Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
WO2015085147A1 (en) 2013-12-05 2015-06-11 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
CA2934073A1 (en) 2013-12-20 2015-06-25 The Broad Institute, Inc. Combination therapy with neoantigen vaccine
EP3757211A1 (en) 2014-12-19 2020-12-30 The Broad Institute, Inc. Methods for profiling the t-cell-receptor repertoire
EP3234193B1 (en) 2014-12-19 2020-07-15 Massachusetts Institute of Technology Molecular biomarkers for cancer immunotherapy
RU2020132040A (ru) 2015-05-20 2020-10-12 Те Брод Инститьют Инк. Общие неоантигены
TW202241500A (zh) 2015-06-09 2022-11-01 美商博德研究所有限公司 用於贅瘤疫苗之調配物及其製備方法
WO2017184590A1 (en) 2016-04-18 2017-10-26 The Broad Institute Inc. Improved hla epitope prediction
WO2018140391A1 (en) 2017-01-24 2018-08-02 The Broad Institute, Inc. Compositions and methods for detecting a mutant variant of a polynucleotide
US20220062394A1 (en) 2018-12-17 2022-03-03 The Broad Institute, Inc. Methods for identifying neoantigens

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES486442A0 (es) * 1978-11-30 1980-12-16 Wellcome Found Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
EP0011865B1 (en) * 1978-11-30 1982-05-19 The Wellcome Foundation Limited Feline infectious peritonitis vaccine and process for its preparation
US4293653A (en) * 1979-04-12 1981-10-06 Horzinek Marian C Method for propagating feline infectious peritonitis virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
CA1303500C (en) * 1986-02-06 1992-06-16 Charles A. Baldwin Feline infectious peritonitis vaccine
EP0264979A1 (en) * 1986-09-05 1988-04-27 Duphar International Research B.V New antigenically active proteins and peptides, and feline infectious peritonitis virus (FIPV) vaccines
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
CA2011025A1 (en) * 1989-03-01 1990-09-01 Terry R. Beardsley Feline infectious peritonitis vaccine
CA2020740A1 (en) * 1989-07-12 1991-01-13 Harry Vennema Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines
US5202430A (en) * 1990-01-16 1993-04-13 University Of Tennessee Transmissible gastroenteritis virus genes

Also Published As

Publication number Publication date
EP0376744A1 (en) 1990-07-04
CA2005291A1 (en) 1990-06-30
ES2078246T3 (es) 1995-12-16
IE67650B1 (en) 1996-04-17
DE68923862T2 (de) 1996-02-08
DE68923862D1 (de) 1995-09-21
GR3017770T3 (en) 1996-01-31
EP0376744B1 (en) 1995-08-16
ATE126537T1 (de) 1995-09-15
AU640356B2 (en) 1993-08-26
CA2005291C (en) 1999-01-26
JPH02291273A (ja) 1990-12-03
DK672789A (da) 1990-07-01
AU4691589A (en) 1990-07-05
JP2903129B2 (ja) 1999-06-07
IE894222L (en) 1990-06-30
NZ231850A (en) 1992-10-28
US5780266A (en) 1998-07-14
DK174187B1 (da) 2002-08-26
US5811104A (en) 1998-09-22

Similar Documents

Publication Publication Date Title
DK672789D0 (da) Nukleinsyresekvens samt rekombinant vaertscelle transformeret med samme
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
ATE507312T1 (de) Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen
LU91396I2 (fr) "La combinaison de la protéine L1 recombinante du papillomavirus humain de types 6,11,16 et 18" -Gardasil/Silgard
DK157186A (da) Ekspression af immunologisk aktive virale proteiner
DK482788D0 (da) Vacciner mod og diagnostiske bestemmelser af haemophilus influenzae
ES2191673T3 (es) Reactivos de diagnostico para la deteccion de anticuerpos contra el virus de epstein barr.
ES2133269T3 (es) Gen receptor del factor de crecimiento derivado de plaquetas de tipo oc.
NO885090D0 (no) Polypeptider.
ATE124420T1 (de) Impfstoffe und testsätze für haemophilus influenzae.
ATE136933T1 (de) Rekombinante hbsag hybridpartikel, die morphologische eigenschaften von hbsag-antigen haben und eine immunogene sequenz enthalten, die neutralisierende antikörper gegen hiv induziert oder die von diesen antikörpern erkannt ist, nukleotide sequenzen, die diese partikel codieren und sie enthaltende impfstoffe
DE60029327D1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
DK0551275T3 (da) Non-A non-B sekvenser

Legal Events

Date Code Title Description
PUP Patent expired